<DOC>
	<DOCNO>NCT00853086</DOCNO>
	<brief_summary>This study conduct Europe . The purpose retrospective study collect additional safety information patient haemophilia inhibitor treat rFVIIa .</brief_summary>
	<brief_title>Post-marketing Safety Surveillance NovoSevenÂ® Patients With Haemophilia Inhibitors Means UK Haemophilia Database</brief_title>
	<detailed_description>Non-interventional , retrospective data collection standard treatment haemophilia A B patient inhibitor UK .</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>All haemophilia A B patient inhibitor treat NovoSeven include No exclusion criterion beyond contraindication describe approved product information text</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>